Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Neuropathic Pain in Carpal Tunnel syndrome
1. Prevalence of Neuropathic Pain (NP) in patients who
underwent Carpal Tunnel Release (CTR) and outcomes of
surgery on Neuropathic Pain
Singapore Orthopaedic Association 41st Annual Scientific
Meeting
Date 3 November 2018
Presenter Tan Chin Hung Mark
Rajaratnam Vaikunthan, Dexter Kuah Le Zhi
2. Background
• Carpal tunnel syndrome (CTS) - commonest compressive
neuropathy (up to 10% of general population)
• Neuropathic pain defined as pain caused by a lesion or disease of
the somatosensory nervous system
• Prevalence of neuropathic pain in CTS reported to be 36%1
2
1Motoki s, The Effect of Carpal Tunnel Release on Neuropathic Pain in Carpal Tunnel Syndrome, Pain Res
Manag. 2017:8098473. DOI:10.1155/2017/8098473
3. Purpose
• Few studies to evaluate prevalence of Neuropathic Pain (NP) in
Carpal Tunnel Syndrome (CTS)
• Purpose of study is to evaluate:
1 ) Prevalence and risk factors of NP in CTS
2 ) Outcome of surgery on NP
3
4. Methodology
• Retrospective study
• Patients who underwent Carpal Tunnel Release for NCS proven CTS
at a tertiary hospital in Singapore from January to July 2018 were
recruited
• 2- part data collection via phone interview and clinical notes
• Neuropathic pain determined by Douleur Neuropathique 4 (DN4)
questionnaire
• Functional outcome determined by QUICKDASH questionnaire
4
6. Methodology
• DN4 has been validated as a screening tool for
neuropathic pain in a number of studies1 2
• Sensitivity of 83%1
• Specificity of 90%1
1. Spallone V1, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA: Validation of DN4 as a screening tool for neuropathic pain in painful diabetic
polyneuropathy. Diabet Med. 2012 May;29(5):578-85
2. Madani SP1, Fateh HR, Forogh B, Fereshtehnejad SM, Ahadi T, Ghaboussi P, Bouhassira D, Raissi GR : Validity and reliability of the persian (Farsi)
version of the DN4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains.. Pain
Pract. 2014 Jun;14(5):427-36
7. Results (Demographics)
• 39 involved wrists in 37 patients
• Average age 54 (± 13 years)
• Average follow up period 5 months (± 2
months)
7
Mal
e
26
%Fe
mal
e
7…
Sex
Rig
ht
67
%
Lef
t
33
%
Op Side
Yes
8%
No
92
%
Steroid
Injections
10. Results
• Pre-op NP associated with side of surgery (p=0.036)
but not associated with age, race, gender or pre-
existing diabetes
• Pre-op corticosteroid injection associated with
worsened QuickDASH score post op (p=0.032)
• Post-op neuropathic pain associated with poorer
QuickDASH score (47.7 vs 19.46)
10
11. Discussion
• Neuropathic pain is more prevalent than what
existing studies suggest
• Even after surgery, 36% of patients still have
neuropathic pain
• More can be done for these patients (Multi-
disciplinary: Pain team, hand therapists etc)
11
12. Discussion
• No similar studies done in Singapore
• Results of this study will be used in informed consent for
carpal tunnel release
• Short follow up; prospective trial with larger sample size
in the pipeline
Editor's Notes
Purpose and background
NP feature of CTS
(no studies done in singapore)
Definition of neuropathic pain
Pain is classified into nociceptive pain and neuropathic pain (NP).
Nociceptive pain is usually acute, develops in response to a specific situation. And tends to go away as the affected body part heals.
Damage or dysfunction of the central or peripheral nervous system induces the development of NP
It is different from nociceptive pain because it does not develop in response to any specific circumstance or outside stimulus.
Purpose and background
NP feature of CTS
(no studies done in singapore)
Definition of neuropathic pain
Pain is classified into nociceptive pain and neuropathic pain (NP). Damage or dysfunction of the central or peripheral nervous system induces the development of NP
QuickDASH score Is a 11 part questionnaire involving activities of daily living and patients had to give a score for each commonent depending on their function. Higher score indicates poorer functional status.
It is a clinician-administered questionnaire consisting of 10 items. Seven items related to pain quality (i.e. sensory and pain descriptors) are based on an interview with the patient and 3 items based on the clinical examination. [1] The DN4 (which stands for Douleur Neuropathique 4) is one of the questionnaires that can be useful in diagnosing neuropathic pain. It has components of how the pain feels to the patient but also requires the examining health professional to assess whether there is reduced sensation (hypoaesthesia) to touch or pinprick and whether light brushing increases or causes pain (allodynia).[2] Questionnaire initially written in French but immediately translated into English by the same team. The scale has been widely used since 2005 because of its simplicity. It evaluates neuropathic pain following central and peripheral neurological lesions.It is also used for diagnostic purposes, allowing the clinician to determine if the pain is of neuropathic origin.[3]
This questionnaire has been well validated in a number of studies.DN 4
Valid for a cut-off value ≥ 4 points [5]
DN4 is valid for painful diabetic polyneuropathy which supports its usefulness as a screening tool for neuropathic pain in diabetes.[5]
Sensitivity
The DN4 questionnaire has very good sensitivity (83%) [5]
Specificity
It has specificity of (90%)
DN4 is a clinician administered questionnaire that has been widely used since 2005 a a screening tool for neuropathic pain due to its simplicity
Sensitivity
The DN4 questionnaire has very good sensitivity (83%) [5]
Specificity
It has specificity of (90%)
Include average f/u time
Average age 53.76
Average pre-op DN4 score 4.76Average post op DN4 score 2.64
Average Preop QD score 49.8
Average postop QD score 29.6
Average age 53.76
Average pre-op DN4 score 4.76Average post op DN4 score 2.64
Average Preop QD score 49.8
Average postop QD score 29.6
Average age 53.76
Average pre-op DN4 score 4.76Average post op DN4 score 2.64
Average Preop QD score 49.8
Average postop QD score 29.6
Include p score
First study in Singapore ?
Limitations next slide- short follow up, prospective trial with larger sample size required
Results of this study will be used as evidence in informed consent for CTR
First study in Singapore ?
Limitations next slide- short follow up, prospective trial with larger sample size required
Results of this study will be used as evidence in informed consent for CTR
Patient have to be properly counselled for regarding prevalence of neuropathic pain even after surgery
However we do not that this study has a short follow up period, and hence a prospective trial with large sample size is in the pipeline